Narval

Seed
narvalbio.com Biotech & Healthcare
Total Funding $4M
Latest Round $4M Seed
Last Announced Jul 14, 2023
Investors Undisclosed
Decision Makers 1 Verified

About Narval

Amping up antibody therapeutics. Break the limits for monoclonal therapeutics with Antibody Mimetic Proteins™.

Sectors & Market Categories

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Seed
Global Headquarters Undisclosed
Tracked Since Oct 1, 2026

Web & Domain Identity

Official Website narvalbio.com
Domain Registered Date Dec 28, 2022

Social & Network Presence

X / Twitter Profile Not linked
LinkedIn Corporate Not linked

Company Milestones & Timeline

2 Events
  1. Capital Raise

    Raised $4,000,000 · Seed

    fundraisingfox.com

  2. Milestone

    Website domain registered

    narvalbio.com

Investors & Backers

Investor firms and individual backers were not publicly disclosed in available round filings for Narval.

Funding History

1 Round
Seed · Jul 14, 2023

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts